Bahy Rehab H, Hamouda Hayam M, Shahat Amal S, Yassin Aymen S, Amin Magdy A
Department of Microbiology, National Organization for Drug Control and Research, Giza, Egypt.
Department of Biochemistry, National Organization for Drug Control and Research (NODCAR), Giza, Egypt.
Jundishapur J Microbiol. 2016 Apr 23;9(4):e30708. doi: 10.5812/jjm.30708. eCollection 2016 Apr.
Streptococcus pneumoniae is still one of the major causes of morbidity and mortality worldwide. The prevalent serotype distribution had shown variation along different studies conducted at different time intervals. In order to efficiently assess the epidemiology of the diseases for effective preventive and treatment strategies, serotype prevalence need to be periodically reassessed.
Conducting a reassessment of the prevalent S. pneumoniae serotypes in Egypt as an essential step in the search for a regional vaccine. In addition, monitoring the antibiotic susceptibility patterns of pneumococcal strains currently causing infections as an evaluation of therapeutic strategies applied.
A total of 100 specimens of different sources were collected in Cairo, Egypt, from 2011 to 2013, representing almost all different types of diseases caused by S. pneumoniae such as meningitis, pneumonia, otitis media and sinusitis. Conventional and molecular identification methods were performed, the antimicrobial susceptibility patterns were assessed and serotyping was done using PCR assays to identify the most prevalent types. In addition, detection of certain virulence genes for the most prevalent serotypes was carried out.
Our results revealed that in Egypt, currently, the most prevalent serotypes were serogroup 6 and serotype 19F as they represented 58% of all isolates. High rates of resistance were found to different antibiotic classes. The lytA and psaA genes were found to be more sensitive for S. pneumoniae identification than ply.
Our study illustrates the importance of constantly monitoring the prevalent serotypes in any region in order to aid in the development of more effective vaccines.
肺炎链球菌仍然是全球发病和死亡的主要原因之一。在不同时间间隔进行的不同研究中,流行血清型分布呈现出差异。为了有效评估疾病的流行病学情况以制定有效的预防和治疗策略,需要定期重新评估血清型流行情况。
重新评估埃及流行的肺炎链球菌血清型,作为寻找区域疫苗的重要一步。此外,监测当前引起感染的肺炎球菌菌株的抗生素敏感性模式,以评估所应用的治疗策略。
2011年至2013年期间,在埃及开罗共收集了100份不同来源的标本,代表了几乎所有由肺炎链球菌引起的不同类型疾病,如脑膜炎、肺炎、中耳炎和鼻窦炎。采用常规和分子鉴定方法,评估抗菌药物敏感性模式,并使用聚合酶链反应(PCR)检测进行血清分型,以确定最流行的类型。此外,还对最流行血清型的某些毒力基因进行了检测。
我们的结果显示,在埃及,目前最流行的血清型是6血清群和19F血清型,它们占所有分离株的58%。发现对不同抗生素类别的耐药率很高。发现lytA和psaA基因对肺炎链球菌的鉴定比ply基因更敏感。
我们的研究说明了持续监测任何地区流行血清型对于开发更有效疫苗的重要性。